Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Republic Healthcare's ROE % or its related term are showing as below:
HKSE:08357'
s ROE % Range Over the Past 10 Years
Min: -35.15 Med: -3.97 Max: 116.33
Current: -35.15
During the past 10 years, Republic Healthcare's highest ROE % was 116.33%. The lowest was -35.15%. And the median was -3.97%.
HKSE:08357's ROE % is ranked worse than 86.9% of 626
companies
in the Healthcare Providers & Services industry
Industry Median: 6.01
vs HKSE:08357: -35.15
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Jun. 2026) net income data. The Revenue data used here is two times the semi-annual (Jun. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Republic Healthcare ROE % Related Terms
Republic Healthcare ROE % Historical Data
* Premium members only.
The historical data trend for Republic Healthcare's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Republic Healthcare's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Republic Healthcare ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Republic Healthcare's ROE % distribution charts can be found below:
* The bar in red indicates where Republic Healthcare's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Jun. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Republic Healthcare (HKSE:08357) has a ROE % of -36.74% as of Jun. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Republic Healthcare and its competitors. According to the industry distribution chart, Republic Healthcare ranks #544 out of 626 companies in the Healthcare Providers & Services industry, placing it in the top 86.9%.
Is Republic Healthcare's ROE % too high?
Republic Healthcare's current ROE % is -36.74%. Based on the distribution chart, Republic Healthcare ranks #544 out of 626 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Republic Healthcare has a GF Score™ of 30/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Republic Healthcare's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Republic Healthcare ranks #544 out of 626 companies for ROE %. This places Republic Healthcare in the lower half of its industry. The industry median ROE % is 6.01. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 6.01, based on 626 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Republic Healthcare and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 6.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Republic Healthcare's current ROE % is -36.74%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Republic Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Republic Healthcare (HKSE:08357) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.09, compared to a current price of HK$0.10 — trading 14.4% above its estimated fair value. The current ROE % is -36.74%. Republic Healthcare's overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Republic Healthcare (HKSE:08357), the current ROE % is -36.74% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Republic Healthcare (HKSE:08357) Overvalued in 2026?
Based on GuruFocus' analysis, Republic Healthcare stock appears to be overvalued.
The current stock price of HK$0.10 is trading 14.4% above its estimated GF Value™ of HK$0.09.
GuruFocus considers Republic Healthcare to be Modestly Overvalued.
Key valuation signals for HKSE:08357:
ROE %: -36.74%
GF Value™: HK$0.09 vs. price of HK$0.10 (14.4% above fair value)
No single metric tells the full story. See the HKSE:08357 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Republic Healthcare Ltd is principally engaged in the clinic business in Singapore and the provision of management advisory services. The company provides healthcare services operating a network of general practice clinics, treatment solutions for common medical conditions with a focus on sexual health and infectious diseases, and operation of a medical aesthetics clinic that focuses on providing treatment solutions for common skin conditions and basic medical aesthetics services. The company is segments are medical services and education services. The Group is engaged in the operation of medical clinics and the provision of management advisory services, pepper trading business, and healthcare-related education business. It generates maximum revenue from Singapore.
30GF Score
Get the complete analysis for HKSE:08357
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08357 has been successfully added to your 
